SlideShare a Scribd company logo
1 of 14
What is Medical Technology ?
• Medical Technology, which is a proper subset of health technology,
encompasses a wide range of healthcare products and is used to
diagnose, monitor or treat diseases or medical conditions
affecting humans.
What is Medical Technologists ?
• Medical Technologists, also known as clinical laboratory
technologists, perform and analyze the results of complex
scientific tests on blood and body fluids.
What is nucleic acid used for in the
human body?
• The nucleic acids are the building blocks of living organisms. You may
have heard of DNA described the same way. Guess what? DNA is just
one type of nucleic acid. Some other types are RNA, mRNA, and
tRNA. All of these "NAs" work together to help cells replicate and
build proteins. NA? Hold on. Might that stand for nucleic acid? It
might.
NUCLEIC ACIDSIN RELATION TO
MEDICAL TECHNOLOGY
THE FOLLOWING ARE SOME OF THE TESTS PERFORMED BY MEDICAL
TECHNOLOGISTS INVOLVING NUCLEIC ACIDS:
NUCLEIC ACID TESTING
BLOOM SYNDROME
LESCH-NYHAN SYNDROME
FANCONI ANEMIA
Nucleic acid testing
• Nucleic acid testing (NAT) is a molecular technique for screening
blood donations to reduce the risk of transfusion transmitted
infections (TTIs) in the recipients, thus providing an additional layer of
blood safety.
• NAAT may also be used to detect other STI pathogens, including
herpes simplex virus (HSV), mycoplasma, ureaplasma, donovanosis,
trichomoniasis and chancroid. The availability of these tests may vary
and may be limited to research settings. Providers should discuss the
appropriate testing options with their local laboratory service.
Bloom Syndrome
Bloom syndrome is an inherited disorder characterized by short
stature, sun-sensitive skin changes, an increased risk of cancer, and
other health problems.
People with Bloom syndrome have low birth weight and length. They
remain much shorter and thinner than others in their family, growing
to an adult height of less than 5 feet.
Lab Studies
The gross overproduction of uric acid is often evident in routine blood and urine
studies.Uric acid levels in the blood typically are elevated, a helpful clue that can
be obtained by routine clinical testing; however, hyperuricemia has many different
causes, and some patients with Lesch-Nyhan disease have serum uric acid levels in
the normal range. As a result, serum uric acid levels do not provide reliable
diagnostic information.
A 24-hour urine sample typically demonstrates a marked increase of uric acid over
normative values, particularly if corrected for patient weight. However, 24-hour
samples are notoriously difficult to collect. Calculation of the concentration ratio of
urinary uric acid to creatinine in a spot urine specimen provides an alternative
method, though less information is available concerning normative values.
Hyperuricosuria is neither sensitive enough nor specific enough to provide reliable
diagnostic information.
Definitive diagnosis is obtained most often by measurement of HPRT
enzyme activity in blood or tissue. Blood samples often are used,
though intact fibroblasts or lymphocytes provide more precise
information with prognostic implications.
Diagnosis is confirmed by identifying a molecular genetic mutation in
the HPRT gene. Molecular genetic diagnosis provides an ideal tool for
carrier detection and prenatal screening of at-risk pregnancies.
Macrocytic anemia, sometimes profound, is relatively common.
Vitamin B-12, folate, and iron levels are typically normal.
Lesch-Nyhan disease
• Lesch-Nyhan disease is a genetic disorder associated with 3 major
clinical elements: overproduction of uric acid, neurologic disability,
and behavioral problems.The overproduction of uric acid is
associated with hyperuricemia. If left untreated, it can produce
nephrolithiasis with renal failure, gouty arthritis, and solid
subcutaneous deposits known as tophi. The neurologic disability is
dominated by dystonia but may include choreoathetosis, ballismus,
spasticity, or hyperreflexia.[3]
The behavioral problems include
intellectual disability (mental retardation) and aggressive and
impulsive behaviors. Patients with the classic disease also develop
persistent and severe self-injurious behavior.
Diagnose
In patients with Lesch-Nyhan disease, uric acid levels in the blood and
urine are typically, but not always, increased. Definitive diagnosis is
generally obtained by measurement of the hypoxanthine-guanine
phosphoribosyl transferase (HPRT) enzyme. Confirmation of the
diagnosis is most reliably made by identification of the HPRT1 gene.
Fanconi Anemia
Fanconi anemia (fan-KO-nee uh-NEE-me-uh), or FA, is a rare,
inherited blood disorder that leads to bone marrow failure.
The disorder also is called Fanconi’s anemia.
FA prevents your bone marrow from making enough new
blood cells for your body to work normally. FA also can cause
your bone marrow to make many faulty blood cells. This can
lead to serious health problems, such as leukemia (a type of
blood cancer).
• Specialists Involved
• A geneticist is a doctor or scientist who studies how genes work and
how diseases and traits are passed from parents to children through
genes.
• Geneticists do genetic testing for FA. They also can provide
counseling about how FA is inherited and the types of prenatal
(before birth) testing used to diagnose it.
• An obstetrician may detect birth defects linked to FA before your
child is born. An obstetrician is a doctor who specializes in providing
care for pregnant women.
• After your child is born, a pediatrician also can help find out whether
your child has FA. A pediatrician is a doctor who specializes in treating
children and teens.
• A hematologist (blood disease specialist) also may help diagnose FA.
Prepared by:
Mercado, Princess Cate R.
Alejandrino, Ma. Lourdes F.
Aspillaga, Liezel

More Related Content

What's hot

BCC4: David anderson on Acute Liver Failure
BCC4: David anderson on Acute Liver FailureBCC4: David anderson on Acute Liver Failure
BCC4: David anderson on Acute Liver FailureSMACC Conference
 
Hepatic encephalopathy by Dr: Mohammed Hussien Ahmed
Hepatic encephalopathy by Dr: Mohammed Hussien AhmedHepatic encephalopathy by Dr: Mohammed Hussien Ahmed
Hepatic encephalopathy by Dr: Mohammed Hussien AhmedKafrelsheiekh University
 
Case Presentation: Management of Hyperparathyroidism following Surgery
Case Presentation: Management of Hyperparathyroidism following SurgeryCase Presentation: Management of Hyperparathyroidism following Surgery
Case Presentation: Management of Hyperparathyroidism following SurgeryJoy Awoniyi
 
Relative adrenal insufficiency
Relative adrenal insufficiencyRelative adrenal insufficiency
Relative adrenal insufficiencyDr. Armaan Singh
 
[2015] hepatic encephalopathy
[2015] hepatic encephalopathy[2015] hepatic encephalopathy
[2015] hepatic encephalopathyAyman Alsebaey
 
Hepatic encephalopathy by dreams
Hepatic encephalopathy by dreamsHepatic encephalopathy by dreams
Hepatic encephalopathy by dreamsDreams Higher
 
Adrenal insufficiency
Adrenal insufficiencyAdrenal insufficiency
Adrenal insufficiencyJin-Yi Hsu
 
PERIOPERATIVE RENAL PROTECTION : WHAT IS THE EVIDENCE?
PERIOPERATIVE  RENAL PROTECTION : WHAT IS THE EVIDENCE?PERIOPERATIVE  RENAL PROTECTION : WHAT IS THE EVIDENCE?
PERIOPERATIVE RENAL PROTECTION : WHAT IS THE EVIDENCE?Dr Jayashree Patki
 
Hepatic encephalopathy presentation latest aspect
Hepatic encephalopathy presentation latest aspectHepatic encephalopathy presentation latest aspect
Hepatic encephalopathy presentation latest aspectJuned Khan
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015samirelansary
 
Acute liver failure
Acute liver failure Acute liver failure
Acute liver failure gagan brar
 
Perioperative Management of Acute Kidney Injury
Perioperative Management of Acute Kidney InjuryPerioperative Management of Acute Kidney Injury
Perioperative Management of Acute Kidney Injurymeducationdotnet
 
Primary Adrenal Insufficiency
Primary Adrenal InsufficiencyPrimary Adrenal Insufficiency
Primary Adrenal InsufficiencyAmer Alboush
 
Rifaximin treatment in hepatic encephalopathy
Rifaximin treatment in hepatic encephalopathyRifaximin treatment in hepatic encephalopathy
Rifaximin treatment in hepatic encephalopathyPratap Tiwari
 
Biomarker for Acute kidney injury
Biomarker for Acute kidney injuryBiomarker for Acute kidney injury
Biomarker for Acute kidney injuryManan Shah
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failureVijay Yadav
 

What's hot (20)

BCC4: David anderson on Acute Liver Failure
BCC4: David anderson on Acute Liver FailureBCC4: David anderson on Acute Liver Failure
BCC4: David anderson on Acute Liver Failure
 
Hepatic encephalopathy by Dr: Mohammed Hussien Ahmed
Hepatic encephalopathy by Dr: Mohammed Hussien AhmedHepatic encephalopathy by Dr: Mohammed Hussien Ahmed
Hepatic encephalopathy by Dr: Mohammed Hussien Ahmed
 
Case Presentation: Management of Hyperparathyroidism following Surgery
Case Presentation: Management of Hyperparathyroidism following SurgeryCase Presentation: Management of Hyperparathyroidism following Surgery
Case Presentation: Management of Hyperparathyroidism following Surgery
 
Relative adrenal insufficiency
Relative adrenal insufficiencyRelative adrenal insufficiency
Relative adrenal insufficiency
 
[2015] hepatic encephalopathy
[2015] hepatic encephalopathy[2015] hepatic encephalopathy
[2015] hepatic encephalopathy
 
Hepatic encephalopathy by dreams
Hepatic encephalopathy by dreamsHepatic encephalopathy by dreams
Hepatic encephalopathy by dreams
 
Adrenal insufficiency
Adrenal insufficiencyAdrenal insufficiency
Adrenal insufficiency
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
PERIOPERATIVE RENAL PROTECTION : WHAT IS THE EVIDENCE?
PERIOPERATIVE  RENAL PROTECTION : WHAT IS THE EVIDENCE?PERIOPERATIVE  RENAL PROTECTION : WHAT IS THE EVIDENCE?
PERIOPERATIVE RENAL PROTECTION : WHAT IS THE EVIDENCE?
 
Periodic paralysis
Periodic paralysisPeriodic paralysis
Periodic paralysis
 
Hepatic encephalopathy presentation latest aspect
Hepatic encephalopathy presentation latest aspectHepatic encephalopathy presentation latest aspect
Hepatic encephalopathy presentation latest aspect
 
Adrenal insufficiency 2015
Adrenal insufficiency    2015Adrenal insufficiency    2015
Adrenal insufficiency 2015
 
Acute liver failure
Acute liver failure Acute liver failure
Acute liver failure
 
Perioperative Management of Acute Kidney Injury
Perioperative Management of Acute Kidney InjuryPerioperative Management of Acute Kidney Injury
Perioperative Management of Acute Kidney Injury
 
Primary Adrenal Insufficiency
Primary Adrenal InsufficiencyPrimary Adrenal Insufficiency
Primary Adrenal Insufficiency
 
Rifaximin treatment in hepatic encephalopathy
Rifaximin treatment in hepatic encephalopathyRifaximin treatment in hepatic encephalopathy
Rifaximin treatment in hepatic encephalopathy
 
Biomarker for Acute kidney injury
Biomarker for Acute kidney injuryBiomarker for Acute kidney injury
Biomarker for Acute kidney injury
 
Acute liver failure in icu
Acute liver failure in icuAcute liver failure in icu
Acute liver failure in icu
 
Addison
AddisonAddison
Addison
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 

Similar to Chapter 5 nucleic acids

Principles of Pathological Investigation and Imaging in Skeletal Disorders
Principles of Pathological Investigation and Imaging in Skeletal DisordersPrinciples of Pathological Investigation and Imaging in Skeletal Disorders
Principles of Pathological Investigation and Imaging in Skeletal DisordersPurvi Verma
 
Approch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age groupApproch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age groupMohammed Saadi
 
Renal diagnostic and Laboratory Tests
Renal diagnostic and Laboratory TestsRenal diagnostic and Laboratory Tests
Renal diagnostic and Laboratory Testsdr salwa alrefaee
 
pcoss.pptx all india institute of medical sciences
pcoss.pptx all india institute of medical sciencespcoss.pptx all india institute of medical sciences
pcoss.pptx all india institute of medical sciencesTorprojectTor
 
lipocaline.pdf
lipocaline.pdflipocaline.pdf
lipocaline.pdfhaneya2
 
lipocaline.pdf
lipocaline.pdflipocaline.pdf
lipocaline.pdfhaneya2
 
Hypertension Hypertension types causes and management complications classific...
Hypertension Hypertension types causes and management complications classific...Hypertension Hypertension types causes and management complications classific...
Hypertension Hypertension types causes and management complications classific...Muhammad Abubakar
 
Hypertension, its causes, types and management
Hypertension, its causes, types and managementHypertension, its causes, types and management
Hypertension, its causes, types and managementAbu Bakar
 
lab investigations in OMFS
lab investigations in OMFSlab investigations in OMFS
lab investigations in OMFSbhanupriya149
 
Hematological laboratory tests
Hematological laboratory testsHematological laboratory tests
Hematological laboratory testsPARUL UNIVERSITY
 
hematologicallaboratorytests-210309102024.pdf
hematologicallaboratorytests-210309102024.pdfhematologicallaboratorytests-210309102024.pdf
hematologicallaboratorytests-210309102024.pdfJoebest8
 
DIAGNOSTIC USES OF ENZYMES.pdf
DIAGNOSTIC USES OF ENZYMES.pdfDIAGNOSTIC USES OF ENZYMES.pdf
DIAGNOSTIC USES OF ENZYMES.pdfLAPULGA7
 
Screening of antihypertensiveagent by raunak
Screening of antihypertensiveagent by raunakScreening of antihypertensiveagent by raunak
Screening of antihypertensiveagent by raunakRaunakkumar Chaurasiya
 
Lupus and your kidneys
Lupus and your kidneysLupus and your kidneys
Lupus and your kidneysLupusNY
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathyRajesh Mandal
 
Enzymes in diagnosis and prognosis 3
Enzymes in diagnosis and prognosis 3Enzymes in diagnosis and prognosis 3
Enzymes in diagnosis and prognosis 3Geeta Jaiswal
 
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsPreclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsChetan Prakash
 

Similar to Chapter 5 nucleic acids (20)

Principles of Pathological Investigation and Imaging in Skeletal Disorders
Principles of Pathological Investigation and Imaging in Skeletal DisordersPrinciples of Pathological Investigation and Imaging in Skeletal Disorders
Principles of Pathological Investigation and Imaging in Skeletal Disorders
 
Approch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age groupApproch to Hematuria in pediatric age group
Approch to Hematuria in pediatric age group
 
Hypertension evaluation 2
Hypertension   evaluation 2Hypertension   evaluation 2
Hypertension evaluation 2
 
Renal diagnostic and Laboratory Tests
Renal diagnostic and Laboratory TestsRenal diagnostic and Laboratory Tests
Renal diagnostic and Laboratory Tests
 
pcoss.pptx all india institute of medical sciences
pcoss.pptx all india institute of medical sciencespcoss.pptx all india institute of medical sciences
pcoss.pptx all india institute of medical sciences
 
lipocaline.pdf
lipocaline.pdflipocaline.pdf
lipocaline.pdf
 
lipocaline.pdf
lipocaline.pdflipocaline.pdf
lipocaline.pdf
 
Csf examination
Csf examinationCsf examination
Csf examination
 
Hypertension Hypertension types causes and management complications classific...
Hypertension Hypertension types causes and management complications classific...Hypertension Hypertension types causes and management complications classific...
Hypertension Hypertension types causes and management complications classific...
 
Hypertension, its causes, types and management
Hypertension, its causes, types and managementHypertension, its causes, types and management
Hypertension, its causes, types and management
 
lab investigations in OMFS
lab investigations in OMFSlab investigations in OMFS
lab investigations in OMFS
 
Gaucher disease
Gaucher diseaseGaucher disease
Gaucher disease
 
Hematological laboratory tests
Hematological laboratory testsHematological laboratory tests
Hematological laboratory tests
 
hematologicallaboratorytests-210309102024.pdf
hematologicallaboratorytests-210309102024.pdfhematologicallaboratorytests-210309102024.pdf
hematologicallaboratorytests-210309102024.pdf
 
DIAGNOSTIC USES OF ENZYMES.pdf
DIAGNOSTIC USES OF ENZYMES.pdfDIAGNOSTIC USES OF ENZYMES.pdf
DIAGNOSTIC USES OF ENZYMES.pdf
 
Screening of antihypertensiveagent by raunak
Screening of antihypertensiveagent by raunakScreening of antihypertensiveagent by raunak
Screening of antihypertensiveagent by raunak
 
Lupus and your kidneys
Lupus and your kidneysLupus and your kidneys
Lupus and your kidneys
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Enzymes in diagnosis and prognosis 3
Enzymes in diagnosis and prognosis 3Enzymes in diagnosis and prognosis 3
Enzymes in diagnosis and prognosis 3
 
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo ModelsPreclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
Preclinical Screening of Antihypertensive Agents | In-Vitro & In-Vivo Models
 

More from Princess Cate Mercado

More from Princess Cate Mercado (8)

Chapter 6 biochemical energy production
Chapter 6 biochemical energy productionChapter 6 biochemical energy production
Chapter 6 biochemical energy production
 
Chapter 2 lipids
Chapter 2 lipidsChapter 2 lipids
Chapter 2 lipids
 
Chapter 4 enzymes and vitamins
Chapter 4 enzymes and vitaminsChapter 4 enzymes and vitamins
Chapter 4 enzymes and vitamins
 
Chapter 3 proteins
Chapter 3 proteinsChapter 3 proteins
Chapter 3 proteins
 
Chapter 7 carbohydrate metabolism
Chapter 7 carbohydrate metabolismChapter 7 carbohydrate metabolism
Chapter 7 carbohydrate metabolism
 
Chapter 9 protein metabolism
Chapter 9 protein metabolismChapter 9 protein metabolism
Chapter 9 protein metabolism
 
Chapter 8 lipid metabolism
Chapter 8 lipid metabolismChapter 8 lipid metabolism
Chapter 8 lipid metabolism
 
Carbohydrates to Medical Technology
Carbohydrates to Medical TechnologyCarbohydrates to Medical Technology
Carbohydrates to Medical Technology
 

Chapter 5 nucleic acids

  • 1.
  • 2. What is Medical Technology ? • Medical Technology, which is a proper subset of health technology, encompasses a wide range of healthcare products and is used to diagnose, monitor or treat diseases or medical conditions affecting humans.
  • 3. What is Medical Technologists ? • Medical Technologists, also known as clinical laboratory technologists, perform and analyze the results of complex scientific tests on blood and body fluids.
  • 4. What is nucleic acid used for in the human body? • The nucleic acids are the building blocks of living organisms. You may have heard of DNA described the same way. Guess what? DNA is just one type of nucleic acid. Some other types are RNA, mRNA, and tRNA. All of these "NAs" work together to help cells replicate and build proteins. NA? Hold on. Might that stand for nucleic acid? It might.
  • 5. NUCLEIC ACIDSIN RELATION TO MEDICAL TECHNOLOGY THE FOLLOWING ARE SOME OF THE TESTS PERFORMED BY MEDICAL TECHNOLOGISTS INVOLVING NUCLEIC ACIDS: NUCLEIC ACID TESTING BLOOM SYNDROME LESCH-NYHAN SYNDROME FANCONI ANEMIA
  • 6. Nucleic acid testing • Nucleic acid testing (NAT) is a molecular technique for screening blood donations to reduce the risk of transfusion transmitted infections (TTIs) in the recipients, thus providing an additional layer of blood safety. • NAAT may also be used to detect other STI pathogens, including herpes simplex virus (HSV), mycoplasma, ureaplasma, donovanosis, trichomoniasis and chancroid. The availability of these tests may vary and may be limited to research settings. Providers should discuss the appropriate testing options with their local laboratory service.
  • 7. Bloom Syndrome Bloom syndrome is an inherited disorder characterized by short stature, sun-sensitive skin changes, an increased risk of cancer, and other health problems. People with Bloom syndrome have low birth weight and length. They remain much shorter and thinner than others in their family, growing to an adult height of less than 5 feet.
  • 8. Lab Studies The gross overproduction of uric acid is often evident in routine blood and urine studies.Uric acid levels in the blood typically are elevated, a helpful clue that can be obtained by routine clinical testing; however, hyperuricemia has many different causes, and some patients with Lesch-Nyhan disease have serum uric acid levels in the normal range. As a result, serum uric acid levels do not provide reliable diagnostic information. A 24-hour urine sample typically demonstrates a marked increase of uric acid over normative values, particularly if corrected for patient weight. However, 24-hour samples are notoriously difficult to collect. Calculation of the concentration ratio of urinary uric acid to creatinine in a spot urine specimen provides an alternative method, though less information is available concerning normative values. Hyperuricosuria is neither sensitive enough nor specific enough to provide reliable diagnostic information.
  • 9. Definitive diagnosis is obtained most often by measurement of HPRT enzyme activity in blood or tissue. Blood samples often are used, though intact fibroblasts or lymphocytes provide more precise information with prognostic implications. Diagnosis is confirmed by identifying a molecular genetic mutation in the HPRT gene. Molecular genetic diagnosis provides an ideal tool for carrier detection and prenatal screening of at-risk pregnancies. Macrocytic anemia, sometimes profound, is relatively common. Vitamin B-12, folate, and iron levels are typically normal.
  • 10. Lesch-Nyhan disease • Lesch-Nyhan disease is a genetic disorder associated with 3 major clinical elements: overproduction of uric acid, neurologic disability, and behavioral problems.The overproduction of uric acid is associated with hyperuricemia. If left untreated, it can produce nephrolithiasis with renal failure, gouty arthritis, and solid subcutaneous deposits known as tophi. The neurologic disability is dominated by dystonia but may include choreoathetosis, ballismus, spasticity, or hyperreflexia.[3] The behavioral problems include intellectual disability (mental retardation) and aggressive and impulsive behaviors. Patients with the classic disease also develop persistent and severe self-injurious behavior.
  • 11. Diagnose In patients with Lesch-Nyhan disease, uric acid levels in the blood and urine are typically, but not always, increased. Definitive diagnosis is generally obtained by measurement of the hypoxanthine-guanine phosphoribosyl transferase (HPRT) enzyme. Confirmation of the diagnosis is most reliably made by identification of the HPRT1 gene.
  • 12. Fanconi Anemia Fanconi anemia (fan-KO-nee uh-NEE-me-uh), or FA, is a rare, inherited blood disorder that leads to bone marrow failure. The disorder also is called Fanconi’s anemia. FA prevents your bone marrow from making enough new blood cells for your body to work normally. FA also can cause your bone marrow to make many faulty blood cells. This can lead to serious health problems, such as leukemia (a type of blood cancer).
  • 13. • Specialists Involved • A geneticist is a doctor or scientist who studies how genes work and how diseases and traits are passed from parents to children through genes. • Geneticists do genetic testing for FA. They also can provide counseling about how FA is inherited and the types of prenatal (before birth) testing used to diagnose it. • An obstetrician may detect birth defects linked to FA before your child is born. An obstetrician is a doctor who specializes in providing care for pregnant women. • After your child is born, a pediatrician also can help find out whether your child has FA. A pediatrician is a doctor who specializes in treating children and teens. • A hematologist (blood disease specialist) also may help diagnose FA.
  • 14. Prepared by: Mercado, Princess Cate R. Alejandrino, Ma. Lourdes F. Aspillaga, Liezel